MYGN
#3315
Myriad Genetics, Inc. - Common Stock
3.1 6 USD
-0.01%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.63%
Monthly Change
-37.67%
6 month change
-37.43%
Year Change
-61.79%
Previous Close
3.1 8
Open
3.1 6
Low
3.1 6
High
3.1 6
Volume
64
Financials
- Market Capitalization 302.25 M
- Employee 2 700
- Founded 1991
- CEO Paul J. DiazPaul J. Diaz
- Website www.myriad.com
- Headquarter Delaware, United States
- FIGI BBG000D9H9F1
- Industry Diagnostics & Research
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-1.56
Price to sales ratio
0.69
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2874 |  FLGT Fulgent Genetics, Inc. - Common Stock | 19.61 USD | -1.70% | -1.41% | -1.16% | -17.01% | 539.57 M USD | ||
| 3015 |  PRE Prenetics Global Limited - Class A Ordinary Share | 25.76 USD | -1.87% | +34.66% | +39.77% | +226.08% | 434.68 M USD | ||
| 3368 |  BDSX Biodesix, Inc. - Common Stock | 26.83 USD | -5.79% | +1.48% | +29.49% | +114.47% | 283.09 M USD | ||
| 3463 |  LAB Standard BioTools Inc. - Common Stock | 0.64 USD | -1.54% | -4.48% | -27.27% | -47.97% | 251.25 M USD |
Frequently asked questions about Myriad Genetics Inc
What is the Myriad Genetics Inc stock price today?
The current price of Myriad Genetics Inc (MYGN) is 3.16. Over the past 24 hours, the stock has changed by -0.63%. Follow the MYGN chart for real-time price dynamics.
What is the stock ticker of Myriad Genetics Inc?
Myriad Genetics Inc trades under the ticker MYGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Myriad Genetics Inc stock going up?
MYGN has changed by -1.25% over the last week, -37.67% over the last month, and -61.79% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Myriad Genetics Inc?
Myriad Genetics Inc currently has a market capitalization of 302.25 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Myriad Genetics Inc earnings last quarter?
Last quarter, Myriad Genetics Inc reported earnings of -0.46 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Myriad Genetics Inc revenue for the last quarter?
Myriad Genetics Inc reported quarterly revenue of 190.7 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Myriad Genetics Inc net income for the last quarter?
Myriad Genetics Inc reported net income of 43.2 M for the last quarter. The previous quarter showed -34.1 M, which means net income changed by +226.69%.
How many employees does Myriad Genetics Inc have?
As of the latest available data, Myriad Genetics Inc has 2 700 employees. Workforce size can provide additional context about the company's scale and operations.
What is Myriad Genetics Inc EBITDA?
Myriad Genetics Inc EBITDA is -18.4 M, and its EBITDA margin is -9.65%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Myriad Genetics Inc stock?
You can buy Myriad Genetics Inc (MYGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Myriad Genetics Inc stock?
Investing in Myriad Genetics Inc requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the MYGN chart and related analysis on metatrader.com as part of your research.